Kilian G.
- Country
- Austria
- Department
- Universitätsklinik für Urologie
Research Overview
- C5731001 - An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)
- Evaluation of BT8009 Monotherapy and BT8009 with Pembrolizumab Versus Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
- Efficacy and Safety of Durvalumab and Bacillus Calmette-Guérin in High-Risk, BCG-Naïve Non-Muscle Invasive Bladder Cancer: A Phase III Randomized Study
Data & Insights
Has run more than one trial at 99 of 260 partner sites.
Specializations
Urothelial Cancer Research
This investigator specializes in treating advanced urothelial carcinoma, with particular emphasis on developing innovative therapeutic approaches for patients with HER2-expressing urothelial cancer.
- First-line treatment strategies
- HER2-targeted therapies
- Combination immunotherapy approaches
Their work explores novel therapeutic combinations including antibody-drug conjugates and immunotherapy agents.
Metastatic Disease Management
The investigator focuses on treating locally advanced and metastatic urothelial cancer, evaluating innovative therapeutic combinations and monotherapy approaches.
- Advanced disease treatment protocols
- Novel therapeutic combinations
- Response evaluation methodologies
Their research encompasses both combination therapy strategies and single-agent treatment approaches.
Early-Stage Bladder Cancer
The investigator specializes in treating non-muscle invasive bladder cancer, with particular focus on high-risk disease management and innovative therapeutic combinations.
- Intravesical therapy optimization
- Immunotherapy combinations
- Disease-free survival strategies
Their research evaluates enhanced treatment protocols combining standard therapies with novel immunological approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.